Results 81 to 90 of about 5,346,158 (173)

Blastic plasmacytoid dendritic cell neoplasm of the skin associated with myelodysplastic syndrome [PDF]

open access: yes, 2015
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a recently described, rare hematologic malignancy with prominent skin involvement. The prognosis of this disease is poor in most cases, with rapid progression despite chemotherapy administration ...
Sang, Hong   +16 more
core   +1 more source

Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation

open access: yeseJHaem
Introduction Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC‐AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Benjamin J. Lee   +5 more
doaj   +1 more source

Blastic plasmacytoid dendritic cell neoplasm of skin, a rare dermatohematologic malignancy—A case report

open access: yesClinical Case Reports
Key Clinical Message Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic malignancy and appropriate diagnosis encounters difficulties in both clinical and pathologic aspects.
Ramtin Edjtemaei   +2 more
doaj   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz   +2 more
doaj  

Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases

open access: yesHaematologica, 2006
CD4+/CD56+ hematodermic neoplasm (WHO-EORTC) or blastic NK-cell lymphoma (WHO) is a rare aggressive (CD4+)(CD56+)lin- skin-tropic lymphoma of putative early-plasmacytoid dendritic cell origin.
AP Ng   +5 more
doaj  

Cutaneous blastic plasmacytoid dendritic cell neoplasm: Report of a case and review of the literature

open access: yes, 2017
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy that usually occurs in elderly individuals and manifests with skin lesions followed by involvement of the lymph nodes, bone marrow, and peripheral blood.
Ming-Ying Wu   +3 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis

open access: yesJAAD Case Reports, 2023
Christopher J. Fay, BA   +4 more
doaj   +1 more source

The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm

open access: yes, 2019
International audienceWe describe the use and value of a lenalidomide/bortezomib/dexamethasone regimen for the treatment of three patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN, a disease that lacks a consensus treatment).
Marmouset, Vincent   +13 more
core   +1 more source

Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm

open access: yesTurkish Journal of Hematology, 2020
Praveen Sharma, Shano Naseem
doaj   +1 more source

Home - About - Disclaimer - Privacy